(Q37107552)

18 August 2017

Local progression among men with conservatively treated localized prostate cancer: results from the Transatlantic Prostate Group (English)

1 reference

18 August 2017

1 reference

Tim Oliver

6

0 references

Daniel Berney

object named as

Daniel M Berney

5

0 references

Jack Cuzick

10

object named as

Jack Cuzick

1 reference

18 August 2017

James A Eastham

1

1 reference

18 August 2017

Michael W Kattan

2

1 reference

18 August 2017

Paul Fearn

3

1 reference

18 August 2017

Gabrielle Fisher

4

1 reference

18 August 2017

Christopher S Foster

7

1 reference

18 August 2017

Henrik Møller

8

1 reference

18 August 2017

Victor Reuter

9

1 reference

18 August 2017

Peter Scardino

11

1 reference

18 August 2017

Transatlantic Prostate Group

12

1 reference

18 August 2017

language of work or name

English

0 references

publication date

30 May 2007

1 reference

18 August 2017

1 reference

18 August 2017

53

1 reference

18 August 2017

2

1 reference

18 August 2017

347-354

1 reference

Long-term outcome among men with conservatively treated localised prostate cancer.

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646888

Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646888

Radical prostatectomy versus watchful waiting in early prostate cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646888

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646888

Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trial

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646888

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646888

Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646888

Deferred treatment of clinically localized low-grade prostate cancer: actual 10-year and projected 15-year follow-up of the Karolinska series

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646888

Results of conservative management of clinically localized prostate cancer.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646888

Deferred treatment in clinically localised prostatic carcinoma.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646888

Incidence of initial local therapy among men with lower-risk prostate cancer in the United States.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646888

Quality of life after radical prostatectomy or watchful waiting.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646888

High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646888

Long-term Survival Among Men With Conservatively Treated Localized Prostate Cancer

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646888

Natural History of Early, Localized Prostate Cancer

3 September 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646888

20 October 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2646888

The need for hospital care of patients with clinically localized prostate cancer managed by noncurative intent: a population based registry study

4 December 2018

1 reference

12 December 2020

A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer

1 reference

12 December 2020

Need for hospital care and palliative treatment for prostate cancer treated with noncurative intent

1 reference

12 December 2020

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial

1 reference

12 December 2020

Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer

1 reference

12 December 2020

10.1016/J.EURURO.2007.05.015

Identifiers

DOI

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

17544572

1 reference